本研究针对前列腺MRI中PI-RADS 3类病灶临床管理难题，通过多阅片者设计对比双参数(bpMRI)与多参数MRI(mpMRI)的诊断准确性。结果显示bpMRI与mpMRI诊断性能无显著差异，阅片者经验与病灶位置显著影响检测率，84-92%病灶保持稳定，支持对选择性病例采取监测策略。

本研究针对重复前列腺活检中PI-RADS 3病变的诊断挑战，通过回顾性分析684例患者数据，发现PI-RADS 3是阴性活检的独立预测因子（OR 0.582），而PSA密度（PSAD）在PI-RADS 4-5病变中具有显著风险分层价值（62.4% vs 33.8%），在PI-RADS 3中则差异有限（20.7% vs 16.2%）。该研究为 ...

Innovative technology performs automatic segmentation and lesion detection in prostate MRI scans to assist in PI-RADS scoring for prostate cancer management TEL AVIV, Israel & SAN JOSE, ...

Upgrade and downgrade rates from targeted biopsy to radical prostatectomy were not significantly different between patients whose MRI examinations were clinically interpreted using PI-RADS Version ...

Real-world homologous recombination repair mutation (HRRm) testing patterns in patients with metastatic castration-resistant prostate cancer (mCRPC) treated with olaparib in the United States. Log Sum ...

Getty Images Use of 68 Ga-PSMA PET/CT may avoid unnecessary biopsies in some men with equivocal PI-RADS 3 lesions on mpMRI. Gallium 68-labelled prostate-specific membrane antigen positron emission ...

An artificial intelligence system slightly outperformed radiologists using PI-RADS at detecting clinically significant prostate cancer. A trained artificial intelligence (AI) system discriminated ...